Absci (ABSI) Free Cash Flow (2020 - 2026)
Absci (ABSI) reported Free Cash Flow of -$26.3 million for Q1 2026, down 20.46% on a YoY basis from -$33.1 million in Q1 2025, and up 9.43% sequentially from -$29.1 million in Q4 2025.
Absci (ABSI) Free Cash Flow (2020 - 2026) Analysis & Trends
Absci (ABSI) has 7 years of Free Cash Flow data on file, last reported at -$26.3 million in Q1 2026.
- For the quarter ending Q1 2026, Free Cash Flow fell 20.46% year-over-year to -$26.3 million; the trailing twelve-month figure through Mar 2026 stood at -$98.5 million (down 28.25% YoY), and the FY2025 full-year result was -$94.0 million, down 29.15% from the prior year.
- Free Cash Flow advanced to -$26.3 million in Q1 2026, from -$29.1 million in the prior quarter.
- In the past five years, Free Cash Flow ranged from a high of -$2.9 million in Q4 2022 to a low of -$32.7 million in Q3 2022.
- A 5-year average of -$19.9 million and a median of -$20.2 million in 2023 frame the typical range for Free Cash Flow.
- Peak annual rise in Free Cash Flow reached 78.02% in 2022, while the deepest fall reached 2586.51% in 2022.
- Tracing ABSI's Free Cash Flow over 5 years: stood at -$2.9 million in 2022, then sank by 407.55% to -$14.9 million in 2023, then retreated by 15.91% to -$17.3 million in 2024, then slumped by 68.13% to -$29.1 million in 2025, then gained by 9.43% to -$26.3 million in 2026.
- Business Quant data shows ABSI's Free Cash Flow at -$26.3 million in Q1 2026, -$29.1 million in Q4 2025, and -$26.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -19.58 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 158.09 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.53 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.29 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 848.30 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -354.95 Mn |
| 10 | Absci | 1.23 Bn | 1.11 Bn | - | -26.34 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -26.34 Mn |
| Mar 31, 2026 | -26.34 Mn |
| Dec 31, 2025 | -29.08 Mn |
| Dec 31, 2025 | -29.08 Mn |
| Sep 30, 2025 | -25.99 Mn |
| Sep 30, 2025 | -25.99 Mn |
| Jun 30, 2025 | -17.10 Mn |
| Jun 30, 2025 | -17.10 Mn |
| Mar 31, 2025 | -21.86 Mn |
| Mar 31, 2025 | -21.86 Mn |
| Dec 31, 2024 | -17.30 Mn |
| Dec 31, 2024 | -17.30 Mn |
| Sep 30, 2024 | -20.47 Mn |
| Sep 30, 2024 | -20.47 Mn |
| Jun 30, 2024 | -17.18 Mn |
| Jun 30, 2024 | -17.18 Mn |
| Mar 31, 2024 | -17.86 Mn |
| Mar 31, 2024 | -17.86 Mn |
| Dec 31, 2023 | -14.92 Mn |
| Dec 31, 2023 | -14.92 Mn |